BIOVIE INC. - Class A Common Stock, par value $0.0001 per share (BIVI)
CUSIP: 09074F405
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Class A Common Stock, par value $0.0001 per share
- Shares outstanding
- 7,932,763
- Total 13F shares
- 1,096,988
- Share change
- +107,789
- Total reported value
- $1,015,118
- Price per share
- $0.92
- Number of holders
- 37
- Value change
- +$95,705
- Number of buys
- 14
- Number of sells
- 17
Quarterly Holders Quick Answers
What is CUSIP 09074F405?
CUSIP 09074F405 identifies BIVI - BIOVIE INC. - Class A Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09074F405:
Top shareholders of BIVI - BIOVIE INC. - Class A Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Acuitas Group Holdings, LLC |
13D/G
|
TERREN S. PEIZER |
16%
|
3,050,394
|
$3,629,969 | $0 | 25 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.8%
|
536,637
|
$525,905 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
138,023
|
$135,264 | — | 31 Mar 2025 | |
| Jonathan M. Adams |
3/4/5
|
EVP Liver Cirrhosis Programs |
—
class O/S missing
|
48,630
|
$82,185 | — | 02 Feb 2022 | |
| Penelope Markham |
3/4/5
|
EVP Liver Cirrhosis R&D |
—
class O/S missing
|
47,841
|
$80,851 | — | 16 Feb 2023 | |
| Steve Gorlin |
3/4/5
|
Director |
—
class O/S missing
|
46,358
|
$78,345 | — | 09 Nov 2023 | |
| Christopher Reading |
3/4/5
|
EVP Neuroscience R&D |
—
class O/S missing
|
37,148
|
$62,780 | — | 16 Feb 2023 | |
| Clarence N. Ahlem |
3/4/5
|
EVP Neuroscience Product Dev. |
—
class O/S missing
|
37,148
|
$62,780 | — | 16 Feb 2023 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0.68%
|
54,100
|
$53,018 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.63%
|
49,811
|
$48,815 | — | 31 Mar 2025 | |
| SANDERS MORRIS HARRIS LLC |
13F
|
Company |
0.5%
|
40,000
|
$39,200 | — | 31 Mar 2025 | |
| Cerity Partners LLC |
13F
|
Company |
0.37%
|
29,330
|
$28,744 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.27%
|
21,613
|
$21,181 | — | 31 Mar 2025 | |
| Richard J. Berman |
3/4/5
|
Director |
—
mixed-class rows
|
63,798
mixed-class rows
|
$19,265 | — | 20 Nov 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.2%
|
16,022
|
$15,702 | — | 31 Mar 2025 | |
| Traynor Capital Management, Inc. |
13F
|
Company |
0.2%
|
16,000
|
$15,680 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.19%
|
15,300
|
$14,994 | — | 31 Mar 2025 | |
| DRIVE WEALTH MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
15,000
|
$14,700 | — | 31 Mar 2025 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.16%
|
13,000
|
$12,740 | — | 31 Mar 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.14%
|
11,280
|
$11,000 | — | 31 Mar 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.14%
|
10,901
|
$10,000 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.07%
|
5,412
|
$5,304 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.06%
|
4,862
|
$4,765 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0.03%
|
2,759
|
$2,704 | — | 31 Mar 2025 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0.02%
|
1,400
|
$1,372 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
1,395
|
$1,367 | — | 31 Mar 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0.02%
|
1,782
|
$1,262 | — | 31 Mar 2025 | |
| Caitong International Asset Management Co., Ltd |
13F
|
Company |
0.01%
|
1,108
|
$1,086 | — | 31 Mar 2025 | |
| Spire Wealth Management |
13F
|
Company |
0.01%
|
1,050
|
$1,029 | — | 31 Mar 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0.01%
|
609
|
$615 | — | 31 Mar 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
598
|
$584 | — | 31 Mar 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.01%
|
418
|
$410 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
190
|
$186 | — | 31 Mar 2025 | |
| Flaharty Asset Management, LLC |
13F
|
Company |
0%
|
100
|
$98 | — | 31 Mar 2025 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
100
|
$98 | — | 31 Mar 2025 | |
| Tradewinds Capital Management, LLC |
13F
|
Company |
0%
|
100
|
$98 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0%
|
97
|
$95 | — | 31 Mar 2025 | |
| Financial Perspectives, Inc |
13F
|
Company |
0%
|
59
|
$58 | — | 31 Mar 2025 | |
| Garde Capital, Inc. |
13F
|
Company |
0%
|
52
|
$51 | — | 31 Mar 2025 | |
| HARBOUR INVESTMENTS, INC. |
13F
|
Company |
0%
|
30
|
$29 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
30
|
$29 | — | 31 Mar 2025 | |
| Financial Gravity Asset Management, Inc. |
13F
|
Company |
0%
|
16
|
$16 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
10
|
$10 | — | 31 Mar 2025 | |
| ALBION FINANCIAL GROUP /UT |
13F
|
Company |
0%
|
5
|
$5 | — | 31 Mar 2025 | |
| Terren S. Peizer |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
65,000
|
— | — | 23 Nov 2022 | |
| Robert J. Hariri |
3/4/5
|
Director |
—
class O/S missing
|
21,815
|
— | — | 20 Nov 2024 |
Institutional Holders of BIOVIE INC. - Class A Common Stock, par value $0.0001 per share (BIVI) as of Q2 2025
As of 30 Jun 2025,
BIOVIE INC. - Class A Common Stock, par value $0.0001 per share (BIVI) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,096,988 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, JANE STREET GROUP, LLC, XTX Topco Ltd, SANDERS MORRIS HARRIS LLC, TWO SIGMA SECURITIES, LLC, NORTHERN TRUST CORP, Traynor Capital Management, Inc., and STATE STREET CORP.
This page lists
37
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
37
Q2 2025 holders
37
Holder diff
0
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.